A Focus on Drug-Induced Liver Injury
Drug-induced liver injury (DILI) is a clinically relevant, costly, and potentially catastrophic condition that affects persons in diverse settings of care. As indications for pharmacotherapy expand with the development of new drugs, so also does the potential for DILI in a greater number of people. The expansion of access to health care, including prescription drug coverage, in the United States may put more persons at risk for DILI. Though not well studied, it appears that recognition of patterns of injury consistent with DILI may not be optimal in primary care and even a more specialized setting.
Source: Clinics in Liver Disease - Category: Gastroenterology Authors: Pierre M. Gholam Tags: Preface Source Type: research
More News: Gastroenterology | Health Management | Liver | Liver Disease | Primary Care | Urology & Nephrology | USA Health